DYN 424B5: Secondary offering
Dyne Therapeutics
Filed with the SEC on · accession 0001193125-26-310573
DYN filed a 424B5 (prospectus (offering)) with the SEC on Jul 21, 2026. Dyne Therapeutics filed a prospectus supplement for a $300 million common stock offering, with an underwriters' option for an additional $45 million. The stock moved +1.6% by the first close after the filing.
Summary of the filing
Dyne Therapeutics filed a prospectus supplement for a $300 million common stock offering, with an underwriters' option for an additional $45 million. The offering is being managed by Morgan Stanley, Jefferies, Evercore ISI, LifeSci Capital, and Raymond James.
Key details
How DYN stock reacted
Close before
$23.45
Jul 20, 2026
First close after
+1.62%
$23.83
5 trading days
+9.30%
$25.63
Since filing
-25.97%
$17.36
✦ Ask GOAX AI about this filing — what it means for DYN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DYN?
Click hereFrequently asked questions
What did DYN file with the SEC on Jul 21, 2026?
DYN filed a 424B5 (Secondary offering). Dyne Therapeutics filed a prospectus supplement for a $300 million common stock offering, with an underwriters' option for an additional $45 million. The offering is being managed by Morgan Stanley, Jefferies, Evercore ISI, LifeSci Capital, and Raymond James.
What does a secondary offering mean for DYN stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did DYN stock react to this filing?
DYN closed at $23.45 before the filing and $23.83 on Jul 21, 2026 (+1.62%). Five trading days later: $25.63 (+9.30%).
Other DYN SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 29, 2026
- 8-K · SEC filingJul 29, 2026
- 10-Q · SEC filingJul 29, 2026
- 8-K · Secondary offeringJul 22, 2026
- 424B5 · Secondary offeringJul 22, 2026
- 8-K · Fda approvalJul 20, 2026
- 8-K · Board changeJun 22, 2026
- 8-K · Material agreementJun 17, 2026
Get alerts when DYN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days